GE's 3D Mammography Device Gets U.S. FDA Approval

By Reuters Staff

September 04, 2014

(Reuters) - General Electric Co's healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer.

According to the company's website, the device, SenoClaire, uses imaging technology that combines low radiation-dosed X-rays from multiple angles to produce a superior mammogram.

The device consists of hardware and software upgrades to the company's previously launched Senographe Essential 2D full-field digital mammography system.

The hardware upgrade produces multiple, low-dose x-ray projection images of the breast. The software upgrade uses the low-dose X-ray images to create cross-sectional views of the breast. (

Hologic Inc came up with one of the first 3-D breast imaging devices in 2001, which continues to dominate the market. Siemens AG submitted its application for the approval of its own 3-D breast imaging device in June.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.